6th Jul 2017 13:48
For immediate release | 6 July 2017 |
Quantum Pharma Plc
('Quantum' or the 'Company')
Result of Annual General Meeting
Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, is pleased to announce that at the Company's Annual General Meeting held earlier today, 6 July 2017, all resolutions put to the meeting were duly passed.
- Ends -
For further information: Quantum Pharma Plc |
| ||
Chris Rigg, Chief Executive Officer | Tel: +44 (0) 1207 279 404 | ||
Gerard Murray, Chief Financial Officer | www.quantumpharmaplc.com | ||
| |||
N+1 Singer |
|
| |
(Nominated Advisor & Broker) |
|
| |
Sandy Fraser / Nick Owen / James White | Tel: +44 (0) 20 7496 3000 |
| |
Media enquiries: Buchanan |
| ||
Henry Harrison-Topham / Sophie Cowles | Tel: +44 (0) 20 7466 5000 | ||
www.buchanan.uk.com |
| ||
Notes to Editors
Quantum Pharma Plc is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesale and hospital markets. Quantum Pharma Plc operates through two divisions - Specials and Niche Pharmaceuticals - offering a portfolio of innovative and complementary products and services.
For further information, please visit www.quantumpharmagroup.com.
Related Shares:
Quantum Pharma